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EVIDENCE BASED MEDICAL QUERY SYSTEM ON LARGE SCALE DATA 
Venkata Pramod Gupta Bavirisetty, Candidate for the Master of Science Degree 
University of Missouri-Kansas City, 2014 
ABSTRACT 
 As huge amounts of data are created rapidly, the demand for the integration and 
analysis of such data has been growing steadily. It is especially essential to retrieve 
relevant and accurate evidence in healthcare and biomedical research. Even though query 
systems based on Ontology, Medical Subject Headings (MeSH), or keyword searches are 
available, query systems based on evidence and effective retrieval of data from large 
collections of clinical data are not sufficiently available.  
This thesis proposes a novel approach to analyze big data sets collected from 
Clinical trials research and discover significant evidence and association patterns with 
respect to conditions, treatment, and medication side effects. Our approach makes use 
of machine learning techniques in the Apache Hadoop framework with support from 
MetaMap and RxNorm. In this thesis, a heuristic measure of empirical evidence was newly 
designed considering the association degree of conditions, treatment, and medication 
side effects and the percentage of people affected. The Apriori algorithm was used to 
discover strong positive association rules with various measures including support, and 
confidence. We have examined a large and complex data set (12,327 study results) 
from clinicaltrials.gov and identified 8,291 strong association rules and 59,228 
combinations with 432,841 subjects, 1761 conditions, 2836 drugs, and 27 side effects. 
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The significance of these association patterns was evaluated in terms of the 
impact factor representing the percentage of the population with a high rate of side 
effects. Using these association rules and combination strengths, an evidence based 
query system was implemented to answer some integral questions. This query system 
also provided an interface to retrieve relevant publications from PubMed. The searching 
outcomes from this query system are compared with those from the PubMed search 
based on medical subject headings. 
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CHAPTER 1 
INTRODUCTION 
1.1 Motivation 
In the medical domain information plays a key role. Over the internet huge 
amount of medical data is created daily and is available freely. There has been huge 
amount of medical research data added to the medical repositories like PubMed [22], 
Clinical Trials [4], Medline plus [17], etc. For effective retrieval of the data, there is a need 
for a query system that searches through the medical data available and presents the 
relevant results efficiently. A general web search engine tries to serve the information by 
retrieving and ranking of user’s query, which has a huge impact on how data is 
represented and organized. This kind of searching causes a serious problem while the task 
is in medical domain.  
 However later new medical query systems were built on medical repositories like 
PubMed [22], Medline Plus [17], Cochrane [5], which provides comprehensive coverage 
of evidence based medical literature. PubMed system mentioned above uses the MeSH 
term for retrieving the literatures. This system provides all the literatures with the 
matching MeSH term in the repository. There is another query system, based on text 
summarization techniques that makes use of the Unified medical language system [28], 
an ontology knowledge source from National Library of Medicine [20]. This system 
queries the data based on the ontologies of the medical terms and returns the literature 
based on ontology mapping. 
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 In order to keep updated with the latest increase in the ongoing research in the 
medical area the practitioners needs an efficient way to retrieve data related to a 
particular domain in the medical field from the datasets. The retrieved results by the 
query system will also need to be reliable and effective, so that this can be linked with the 
online literatures to get the relevant online medical evidence. As the practitioners deals 
with variety of areas such as diagnosis, treatment, therapy, etiology the linked literature 
should be contextually relevant and this would provide potential benefits to the Health 
Practitioners. 
1.2 Problem Statement 
 The medical query systems available online provides an evidence based query 
system on the online medical literatures available by making use of the MeSH term or the 
ontologies related to the medical search term. Due to the growth of medical data over 
the internet, the effective retrieval of data from the data set is becoming very expensive 
and time consuming. Due to this, the support for query systems on large volumes of 
scientific data is becoming increasingly important.  
 The queries in the current systems were based on ontologies or Mesh terms. 
These applications does not provide results based on the side effects or the percentage 
of people effected or the test groups that were considered at the time of research. Using 
this information for querying would facilitate the practitioners with much relevant and 
effective medical literature. 
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1.3 Thesis Outline 
The thesis focuses on two important problems that usually occur at the time of 
querying the medical data repositories. The first problem is the big data challenge which 
requires high computational resources to query effectively and efficiently. The second 
problem is the related literature being resulted from the query system using the evidence 
available. All the query systems available online results the queries based on the either 
keyword or Ontologies or MeSH term but not on the side effects or the percentage of 
people effected or any other evidences. 
For the thesis, we have considered Clinical Trials [4] as the data set. This data 
compromises of medical studies on conditions, studies with results and proposals on 
medical conditions and use of combination of drugs for a condition and the side effects 
and the medical groups used for these studies. This also compromises of the statistics like 
the group size, group properties, drugs, time period etc.  We have considered 12,327 
research studies for the thesis. 
In this thesis we present our work towards building a high performance data 
analysis on distributed system using MapReduce. The system processes the clinical data 
and pull the required data from the entire dataset. For high performance querying, the 
data from the distributed system is loaded into a centralized system and a PHP query 
system is built on top of it. We have observed 1761 unique Medical conditions and 2836 
unique drugs used in the entire studies. 
In order to provide the results based on the evidence, we use the condition, drug 
and side effect combination and the frequency of this combination in the overall data set 
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and the percentage of people effected with this side effect in the overall data set. Along 
with the above method, we used association rule mining on the data to find the relevant 
association rules. 
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CHAPTER 2 
RELATED WORK 
2.1 Overview 
 In this chapter, we will discuss about the Existing Medical Query Systems, Existing 
Large Scale based Query Systems. We will go through the query criteria’s of the existing 
systems and compare them with the model that is presented in the thesis. 
2.2 Problems of Existing Medical Query Systems 
 Most of the current search engines only perform a shallow string processing 
because of the lack of understanding of natural languages and human intelligence which 
leaves the users the users to go through pages of results to find the relevant literatures. 
Usage of Ontologies provided much better results by using the ontologies, related to the 
users search query. The documents are summarized using the taxonomies which lets it 
retrieval much faster. But most of these search engines does not make use of the 
evidences provided from the research documents which could be helpful in much better 
retrieval of the relevant information.  
 The amount of medical information available online is growing rapidly and this 
leaves us with the Big Data issue. Most of the medical query systems available online does 
not make use of the Large scale framework for processing the information. 
2.3 Existing Medical Query Systems 
 Medical query systems allow us to search and retrieve information from the 
medical repositories. Existing medical query systems use different methods for searching 
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the repositories such as Keyword or Ontology or Mesh terms. Some of the Medical 
Systems use either Keyword or Ontology or Mesh terms to search the datasets.  
Search by Keyword: 
 This is the most traditional search where the user can search medical content by 
using keywords, the search engine returns the documents which has those keywords in 
the document used by the user while querying [16]. These query systems usually store 
the medical information in the relational database [3] and search the database using the 
keywords and retrieves the related medical documents. Some query systems usually 
search the medical documents for the keywords and retrieve the documents matching 
the keyword criteria. Usually the search engines rank the documents according to the 
user’s query and organize the data and present it to the user. 
Search by Ontology: 
 Many applications use ontology [7] for querying medical repositories. Usually 
most of the query systems use some of the online available medical ontology repositories 
to get all the information related to the medical terminology. Ontologies are descriptions 
of the concepts and relationships. Most of the repositories use either Unified Medical 
Language system (UMLS) [28] or National Library of Medicine (NLM) [20]. Usually some 
query systems [21] revise the users search query with the ontology knowledge and adds 
the relevant terms. Then distance of each sentence in the document is calculated. If the 
distance is less than the threshold then they are included in the output. 
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 Some other algorithms use the ontologies for getting the related terminology for 
the keyword and the use all the keywords for lexical searching [16]. Here all the keywords 
collected from the ontology repository are searched in the document. Then the 
documents with most keywords available are retrieved and presented the user. 
Search by MeSH Term: 
 This is the kind of search used by the PubMed [22] for retrieving the medical 
articles. Initially all the articles inserted into the PubMed are examined, and the most 
specific MeSH (Medical Subject Headings) [22] terms with a related heading and sub 
heading, typically ten to twelve are assigned to each citation. 
 Each MeSH term is added into the database for each citation and the indexes are 
updated every week for all the citations in the repository. MeSH terms are arranged 
hierarchically by subject categories with more specific terms arranged beneath broader 
terms. Once a search is done PubMed automatically explodes the search by including all 
the narrower terms. These MeSH terms are searched against the database consisting of 
the MeSH terms related to the each citation and the related citations were returned to 
the user.  
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Table 1: Comparison between Medical Query Systems 
Query System Query Type Ontology 
Source 
Large Scale 
Framework 
Output 
Criteria 
Machine 
Learning 
Algorithm 
High 
Performance 
Spatial Query 
System[1.] 
Spatial 
Objects 
based 
Queries 
No Hadoop - None 
Query 
Expansion 
Framework 
System[34] 
Ontology 
based 
NLM No Concept 
threshold 
None 
MedSearch[24] Semantics 
based 
NLM No 
 
- None 
PubMed[13] MeSH term 
based  
MeSH No No. of MeSH 
terms 
None 
Language Query 
Patterns Query 
system[9] 
Keyword 
based 
UMLS No Keyword 
Ranking 
None 
Medical 
Information 
Summarization 
System[1] 
Ontology 
based  
UMLS No Distance 
based 
Keyword 
ranking 
None 
Evidence based 
Query model 
Keyword & 
MetaMap 
MetaMap Hadoop Combination 
Strength 
Apriori 
Rule 
Mining 
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2.4 Existing Large Scale based Query Systems 
 Support for high performance queries on large volumes of medical data is 
becoming increasingly important in many applications. The major requirement for such a 
query model is effective querying of large amounts of data with fast responses, which is 
faced with two major challenges: the “Big data” challenge and high computational 
complexity. Some of the query systems available [1] makes use of the MapReduce [13] 
paradigm for querying the large amount of data. This query system uses spatial queries 
to query the data. Usually the method followed consists of the following steps: Object 
Segmentation, Region Segmentation, Feature extraction and Data Management and 
Queries. Usually these systems make use of the Hadoop Environment [13] and 
MapReduce paradigm to process the large amounts of data. 
2.5 Summary 
 As we have discussed above, all the medical query systems available online are 
not compatible for large scale data. Most of the medical query systems either use 
keyword or ontology or MeSH terms for querying the systems but none of the query 
systems use evidence from research studies for querying the data. 
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CHAPTER 3 
EVIDENCE BASED MEDICAL QUERY MODEL 
3.1 Overview 
In this chapter, we will discuss about the Evidence based medical query model. 
This includes collecting data from the Clinical trials site [4] and loading the data into the 
Hadoop cluster [13] that has been setup in the local for filtering the data in parallel using 
the MapReduce Paradigm. 
The data obtained from the Clinical Trials [4] is stored is in the XML format. The 
data consists of all the information related to the research done by the teams on the test 
subjects. The data is filtered and linked with MetaMap [8] for collecting the related 
medical terms and Meta Score. For each combination of Condition, Drug and Side effect 
the percentage of people affected and the frequency of the combination in the entire 
data set is calculated. Using these two parameters the strength of the combination is 
calculated and is used to order the data returned by querying the data model. Apriori 
association rule mining algorithm is used on the data retrieved from the clinical trials and 
association rules were generated. 
The resulted data from the model is used to link with PubMed [22] to pull the 
related publications containing all the variables in the combination. The data model can 
also be used as a simple query system and link the results with RxNorm[24] to pull the 
related drug details. 
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3.2 System Architecture 
The architecture consists of a query interface where the user can input the query 
term onto the model. The webserver consists of the data model which is loaded from the 
Hadoop environment [13]. The data analysis and MetaMap linking were explained in the 
architecture diagram. The architecture diagram shows how the query is sent to the 
webserver and linked with PubMed [22] and RxNorm [24]. Here in the figure all the orange 
color represents the models used or implemented within the system where as the sky 
blue represents the external models. 
 
Figure 1: System Architecture 
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3.3 Clinical Trials Data Extraction and Loading 
 In this section, we will look into the detailed process of extraction and loading of 
the data. The data is collected from the Clinical Trials [4] in the XML format. Only the 
studies with results were selected as to get the evidence to query the system depending 
upon the search terms.  
 The data downloaded from the clinical trials [4] consists of all the information 
related to the study like condition, drugs used, side effects, details of the test group used, 
percentage of people affected by side effects in the test group, duration of the test etc.  
The data collected from the clinical trials is loaded into the Hadoop Environment [13] in 
order to process the data in parallel. This environment provides the platform which can 
be used for data analysis on large amounts of data in a pretty efficient way by processing 
the data in parallel. A Hadoop cluster [13] is used, which consists of three data nodes for 
the processing of the data. The initial task is to load the data into the Hadoop 
Environment. The loaded data is broken into file splits and stored in the three data nodes 
with a replication factor of two (i.e. for each split size of 64MB, two copies of the split) 
are stored in the three data nodes. The namenode of the cluster stores the meta 
information of the file splits like location and offset of the split. This split enables the 
parallel access of the data across the cluster. 
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Figure 2: Clinical Trials XML Data 
3.4 Data Filtering and Linking with MetaMap 
 The data loaded into the Hadoop Environment [13] consists of all the information 
related to the research studies. We do not need all the information related to the study 
for building the Evidence based Data Model. We only need the condition, drugs used, side 
effects observed, percentage of people affected in the group used. For collecting only the 
required data from the data set we use the MapReduce Paradigm to filter the data.  
 The MapReduce takes the file split stored in the data node and reads each XML 
node in the split and checks if it matches with the required nodes and if it matches, then 
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it writes the node name and the node data to the context along with the file split name. 
All this is done in parallel by the map jobs and once all the map jobs are done, the data 
written to the context is sent to the reduce job. The reduce job writes the data collected 
from each map into an XML format with only the required data. 
Consider the following example: 
  Condition - > Prostate Cancer 
Drug -> Degarelix 
SideEffect ->  Vascular disorder 
Study ID-> NCT00000300 
Group size-> 24 
 People Affected-> 3 
MapReduce 
Input Clinical Trials data into Map 
Data is shared among the maps. 
Each document sent to the Map is read and required fields are written to the Context 
All the data is aggregated and sent to the Reduce 
While Context has data 
 Each row is aggregated and written to the External XML file 
End While 
   
 
 
15 
 
 
Figure 3: Clinical Trials Data 
 
 Once the data is extracted, the conditions are linked with MetaMap [8] to find the 
related medical terminology of the conditions and find the Meta Score of the condition 
which relates the condition to the Medical relativeness. This metascore is used to filter 
the data more from the new XML data set. 
Consider the following example:  
When “Breast Cancer” term sent as an input to MetaMap we get the following Medical 
terms :  Ductal Carcinoma 
Lobular Caricoma 
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3.5 Building Data Model based on Evidence 
 The data collected after filtering and linking with MetaMap [8] is used as the data 
model for the query system. The data is loaded into the MySQL database [18]. Each 
combination from the XML document is taken along with the related medical terminology 
and loaded into the table. While loading into the table the frequency of the combination 
is checked in the table and average of the percentage effected were calculated and stored 
in the table. 
 Once the entire data is loaded into the database, the strength of each combination 
is calculated in the MySQL database [18]. The strength of each combination is calculated 
by taking the frequency and percentage effected of the combination. 
Strength  =   (Frequency) / (Percentage affected)2 
Frequency = No. of Occurrences of combination in the entire dataset 
Percentage affected = People affected percentage among all the test subjects  
This formula is in reference to the Medley Clement’s formula [10] for comparing groups 
with respect to the factors. 
  Omega = (f1)/ (f2)2 
 
Consider the following example:  
 Prostate Cancer -> Degarelix -> Vascular Disorder -> 7% 
Prostate Cancer -> Degarelix -> Vascular Disorder -> 9% 
Average Percentage = 8%,  Frequency = 2 
Strength = 2/(8)2 = 0.0312 
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 In Figure 4, the relationship between condition, drug and sideeffect are 
expalined. Each entity is related to the other using the frequency of occurance of the 
combination in the entire dataset.   
 
Figure 4: Combination Relationship 
In Figure 5, the steps involved in loading the data into the MySQL database are explained. 
 
Figure 5: Hadoop to Webserver Migration 
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3.6 Association Rule Mining 
 In this section, we will discuss how we used association rule mining on the clinical 
trials data. The Apriori algorithm is used against the data to find the association rules 
among the data. 
 Apriori is the best known association rule mining algorithm. It starts with 
identifying the frequent individual items in the set and extends them to large item sets.  
Apriori Algorithm: 
     
Figure 6: Apriori Algorithm 
Support and Confidence are the two important concepts of Apriori algorithm. 
 Support of an itemset Supp(X) is defined as proportion of transactions in the 
dataset which contains the itemset. 
Ex:  {Prostate Cance } => {Blood disorder} has support 20% 
           It means 20% of the records in the entire dataset consists of Prostate Cancer 
and Blood disorder. 
 Confidence of a rule is defined as Supp(X U Y)/Supp(X). 
Ex:  {Prostate Cancer, Degarelix} => {Blood disorder} has confidence 1 
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           It means 100% records consisting Prostate Cancer, Degarelix also consists of 
Blood disorder 
3.7 Querying the Data Model 
 In this section, we will discuss how we query the data model. We have built a data 
model where the combination (Condition, Drug, Side effect) consists of frequency, 
percentage affected and the strength. Using the strength parameter we present the 
results to the user which are more effective rather than querying only using keyword 
search.  
 When the user queries the system, a SQL query is built using the search term the 
user has entered and the search type the user selected. The search type consists of three 
options namely condition, drug and side effect where the user can select the type for 
querying. The resultant SQL query would look something like this: 
Select * from table where “search_type” like “%search_query%” order by strength desc 
 The above query searches the table depending upon the search term and order 
the results by the strength. Because of the ordering of the results using strength, the most 
effective combination available in the data set will be presented to the user. 
3.8 Linking Data Model with PubMed & RxNorm 
 The data model is linked with PubMed [22] to pull the publications related to the 
combinations found by querying the model. When the user queries the system, the 
combinations with the most effective value are returned. PubMed [22] provides an API in 
order to get publications related to a term. We use this feature of PubMed and pull the 
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publications using all the combinations. In this way, after querying the model for the 
effective combination, the combination is sent to the PubMed API and this would result 
in publications consists of all the combinations (Conditions, Drug and Side Effect). Linking 
of the model with PubMed would provide a platform to obtain more effective 
publications related to the search term. 
 The data model is also linked with RxNorm [24], a drug database. RxNorm provides 
an API to query their data model and find related drug information. The information 
consists of all the available forms of the drug in market, possible physiological effects, 
psychological effects, compatibility with other drugs and usage restrictions at the time of 
particular medical conditions. This information is presented when the user queries the 
system. Using the drug from each combination, related information is acquired using the 
RxNorm API. 
3.9 Summary 
 In this section, we have discussed the system architecture of the evidence based 
medical query on large scale data. Data Extraction and filtering steps were explained in 
this section. The various steps in building the query model were explained in this section. 
Overview of how the model is linked with RxNorm and PubMed models were also 
discussed in this section. 
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CHAPTER 4 
IMPLEMENTATION 
4.1 Introduction 
 In this chapter, we will discuss the complete implementation of the system 
starting with the setup of the Hadoop cluster followed by MetaMap setup, MapReduce 
API for data analysis, MetaMap linking, Loading data into MySQL, Calculating the strength, 
building the PHP query system, linking the results with RxNorm, linking the results with 
PubMed API. 
4.2 Hadoop Cluster Setup 
 In this section, we will look into detailed procedure of setting up the Hadoop 
cluster in the local machine. The following steps are involved in Hadoop Cluster setup: 
1. In order to build a cluster of Hadoop nodes in a single system, we need to use a virtual 
box so that each instance of Hadoop sits on one virtual machine. For this we installed VM 
Ware Workstation, which is an open source application. 
2. We downloaded the CentOS iso file to setup linux environment on each virtual instance. 
For creating a linux instance, I created a new virtual machine in the workstation and 
loaded the CentOS iso file into the virtual machine. This step will setup the linux 
environment on the virtual machine. 
3. After the setup of the linux environment on the virtual machine, Java is installed on the 
machine as it is a prerequisite for Hadoop. Java is installed using the following steps: 
i. Download latest JDK from Oracle 
ii. Extract and install java on the machine. Command :  (rpm –Uvh jdk.rpm) 
22 
 
4. Once java is installed, SSH is configured as Hadoop uses it to manage and access each 
node in the cluster. SSH can be configured using the following steps: 
i. Move to the root folder in the terminal. Command : (cd ~) 
ii. Command to generate public and private RSA key pair. Command : (ssh-keygen) 
iii. Copy public key to authorized keys so that SSH doesn’t need password every time. 
Command : (cat ~/.ssh/id_rsa.pub >> ~/.ssh/authorized_keys) 
iv. Changing permission of the authorized keys folder. Command :(chmod 700 
~/.ssh/authorized_keys) 
5. Next we have installed the Hadoop by downloading the hadoop-1.2.1 which is a stable 
version available in apache server. Installation is done following the below steps: 
i. Extract the files from the download location. Command : ( Tar –xvf Hadoop-1.2.1.tar ) 
6. Then for Hadoop to recognize the java available on the machine, the bashrc file is edited 
with the Java home and Hadoop home locations. 
i. export JAVA_HOME = /usr/java 
ii. export HADOOP_HOME = /usr/local/hadoop 
iii. export PATH=$PATH:$HADOOP_HOME/bin:$PATH:$JAVA_HOME/bin 
7. Now core-site.XML file in the Hadoop conf folder is edited with the following changes: 
<property> 
 <name>fs.default.name</name> <value>hdfs://localhost:54310</value> 
</property> 
8. Then mapred-site.XML file is edited to configure the job tracker location 
<property>  
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<name>mapred.job.tracker</name>  
<value>localhost:54311</value>  
</property> 
9. Then hdfs-site.XML file is edited to configure the replication factor of the system. 
<property> 
<name>dfs.replication</name> 
<value>1</value>  
</property> 
10. Once the files are edited, then the namenode is formatted in order to start the cluster. 
Format the namenode. Command : (hadoop namenode –format) 
11. Then all the services on the cluster are started by using start-all.sh command 
12. This process completes the setup of a single node in the cluster. 
13. The same process is used to configure 2 more nodes in the cluster.  
14. Once all the nodes are setup with the Hadoop, then each node ip address is update in the 
hosts file in each node 
gedit /etc/hosts 
15. Then all the iptables in all the nodes are stopped, so that one node can communicate with 
other 
Stop the iptables. Command : (Service iptables stop) 
16. In this way, the Hadoop multi node cluster is configured. 
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Figure 7: Hadoop Cluster 
4.3 MetaMap Setup 
 In this section, we will look into the detailed procedure of configuring the 
MetaMap server and the MetaMap Java API in the local machine. The installation 
procedure is as follows: - 
1. The MetaMap distribution 2013 for windows is downloaded from the NLM server [20] by 
creating an account in the nlm MetaMap server. 
2. By running the MetaMap executable file and configuring the distribution location in the 
machine the installation gets completed. 
 
Figure 8: MetaMap Setup 
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3. Then we started the SKR MEDPOST Part of speech Tagger server to run the MetaMap 
services. 
i. Move to public_mm folder in command prompt 
ii.  Medpost server is started in order to find the mappings. Command: (bin/skrmedpostctl 
start.bat) 
4. After starting the Medpost server in a new terminal Word Sense Disambiguation (WSD) 
Server is started 
bin/wsdserverctl start 
5. Once the server setup is done, the Java API is installed on the system as the application 
needs to programmatically communicate with the MetaMap server and pull the required 
data. 
i. Java API folder is extracted into the public installation of the MetaMap files. 
ii. Install.exe file is executed in the public directory for configuring the java API. 
6. After the installation, the MetaMap server is started. 
Command: (bin/mmserver13) 
7. This step wraps up the complete setup of the MetaMap server along with the java API in 
the local machine. 
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4.4 MapReduce  
 In this section, we will discuss how we have used the MapReduce programming 
paradigm to extract the required data from clinical trials and detailed implementation of 
the map and the reduce phase. 
 We have downloaded the entire medical studies with results from the clinical trials 
website in the XML format. The downloaded data consists of all the information related 
to the study like the study id, conditions, interventions, age groups, drugs used, 
description of the drugs, study groups, start date etc. We only require the condition, 
drugs, side effects if any and the percentage of people affected.  
 We configured the input and output format of the MapReduce job in the 
configuration section in the main function. Using a custom Input format class the clinical 
trials data is loaded into the system. The custom input format is implemented as shown 
in the Pseudo code mentioned below: 
XMLInputFormat1 extends TextInputFormat 
{ Calls custom XML recorder function(); 
}  
XML recorder{ 
Takes the input split of the XML file 
Start = split.start(); // Sets the start of split as open tag 
End = split.end(); // sets the end of split as end tag 
Sets the start from the start position 
} 
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Input to the Map phase is in the custom format which consists of each node from 
the XML split read. In the map phase when the input matches to any of the required 
nodes, then the node name and its value will be written to the context. The map jobs are 
scattered across all the three nodes and will write the data read to the context in parallel. 
Map(){ 
 XMLStreamReader reader; // XML streamreader is created   
 //Nodes required in the output are added to string array 
   String ele[] = {"condition", intervention_type", "intervention_name", "enrollment", 
"gender",  };  
 //Stream reader is looped till it reaches the end 
      while (reader.hasNext()) {  
  //If elements is present in array 
  If(ele.contains(reader.next())) 
  {  
   // Writes the node name and value to the context for the reduce 
function 
        Context.write(reader.getName(),reader.next()); 
       } 
} 
Reader.close(); }  
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Once all the map jobs are finished, then the program moves into the reduce phase. 
The input to the reduce phase would be in the text format of key value pairs. The reduce 
phase reads the nodes and their values and writes it to the context in the XML format 
with only the required fields for the data analysis. 
 
Reduce() 
{ // For each element in the iterator, the item is written to context 
 Foreach(iterator ) 
 {   // Node name and node value is written to context in XML format 
     context.write(new Text("<property>"), null);  
          context.write(node.value, null);  
          context.write(new Text("</property>"), null); } } 
4.5 MetaMap Linking  
In this section, we will discuss about how the medical conditions were linked with 
MetaMap mappings and all the data that is considered and stored after linking with the 
MetaMap. The output from the MapReduce is taken and each condition in the input file 
is taken by using XQuery as mentioned below: 
expr = xpath.compile("//condition/text()"); 
This query pulls all the conditions from the XML input. A MetaMap object is 
created and each condition is sent to the object and the preferred names and meta score 
are pulled and written to a new map file.  All the conditions with the meta score greater 
than 950 were considered. 
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MetaMapAPI API = new MetaMapAPIImpl(); 
List<Result> resultList = API.processCitationsFromString(terms); 
for (Result result : resultList) { 
for (Utterance utterance : result.getUtteranceList()) { 
      for (PCM pcm : utterance.getPCMList()) { 
  for (Mapping map : pcm.getMappingList()) { 
         for (Ev mapEv : map.getEvList()) { 
       preferred_names.add(condition,mapEv.getPreferredName()); 
     if(, mapEv.metaScore() > 950)  
                               scores.add(condition, mapEv.metaScore()); 
   } } }  } 
 
4.6 Data Loading into MySQL 
 In this section, we will discuss how the data is loaded into the MySQL database 
and how the frequency and the strength of the Condition, drug and side effect were 
calculated.  
 Each study from the output XML of the map reduce job is considered and checked 
if this is available in the map that is generated by linking to the MetaMap. If this condition 
is available in the map then the related drug, side effect and the percentage of people 
effected with this combination are considered. Using a MySQL connector, a connection 
can be established to the MySQL database from the java program. 
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        Connection con = null; 
        String URL = "jdbc:MySQL://localhost:3306/testdb"; 
        String user = "testuser"; 
        String password = "test623"; 
       //Establishing Connection to the databse 
       con = DriverManager.getConnection(URL, user, password); 
For each combination obtained the Condition, drug and the side effect is checked 
if available in the table.  If available, then the frequency and the percentage effected were 
taken and the average of the percentage effected is calculated and the frequency value 
is increased by a value of 1. The structure of the table that stores the below data is as 
follows: 
 
Figure 9: Database Table Design 
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Once all the data is loaded, then the strength of the combination is calculated by 
taking the frequency and the percentage effected. 
Strength  = frequency / (percentage_effected)2     // when percentage_effected != 0 
This strength value will be used by the query system to order the results. 
4.7 Query System 
In this section, we will discuss how the query system is implemented and the 
technologies used in the implementation process. The data is stored in the MySQL 
database and SQL is used to retrieve the data from the database. The query page consists 
of a text box to collect the query text and a dropdown menu to select the type that 
needed to be queried. The query page looks like this: 
 
Figure 10: Medical Query System 
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Figure 11: Medical Query System PubMed Module 
 
 Once a query term is searched, the query term along with the type is sent back to 
the same page by post method.  
<form method="POST"> 
<input type="text" name="query" id="query" value="Enter the search term over here"  
 <select name="search_type"> 
  <option value="condition_name">Medical Condition</option> 
  <option value="drug">Drug</option> 
  <option value="sideeffect">Side Effect</option> 
</select>                      
<input type="submit" value="Search" /></div> 
</form> 
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When the page comes back to the post mode, the post variables i.e. query text 
and query type are collected and used to run the query on the table. The output results 
were order by the strength so that the most effective results will be show first. 
 // When page returned by post request the below code runs 
if (strtoupper($_SERVER['REQUEST_METHOD']) == 'POST') 
{  // Gets the values from the post opbject 
$searchtext = $_POST['query']; 
$search_type = $_POST["search_type"]; 
//  Query to search the table by the requested parameters from the search request 
$query = "select condition_name, drug, sideeffect from medical_new where 
".$search_type." like '%".$searchtext."%' order by strength desc"; 
//  Runs the sql query on the database table 
$result = MySQLi_query($con, $query); 
} 
 
 The above query returns all the conditions, drug and the side effect that matched 
the above search text given as input by the user. All the rows returned were looped 
through and the results were written to the page in the order. The below codes does the 
writing to the page: 
// Reads each row returned by the query 
while($row = $result->fetch_array()) 
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  { // Builds the table element in the loop 
 echo "<tr>"; 
       echo "<td>".$row["condition_name"]."</td>"; 
   echo "<td >".$row["drug"]."</td>"; 
  echo "</tr>"; 
  } 
 
4.8 Linking Model with RxNorm  
 In this section, we will go through all the steps to link with RxNorm API and the 
information provided by the RxNorm. The Rx Norm API provides the following information 
for the drugs: 
i. Available modes in market  
ii. Conditions with which drug cannot be used  
iii. Conditions that can be treated with the drug 
iv. Physiological Effects 
v. Psychological Effects 
vi. Drugs that can inhibit the effect of the actual drug 
vii. Conditions that can be induced by the drug 
viii. Conditions that can be prevented by the drug 
RxNorm provides a RESTful web service. The complete details of the drug can be 
found by using the Rx Concept id. In order to get the details of the drug, firstly we need 
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to find the concept id and then use that concept id to pull the information. The Concept 
id can be found by sending the drug name to the following API by appending to the URL. 
This would give an XML output and the concept id is taken by parsing the XML document 
resulted from the API call. The code for the API call and parsing the output are mentioned 
below. 
// RxNorm web URL for concept id 
$URL = 
"http://rxnav.nlm.nih.gov/REST/Ndfrt/search?conceptName=".$conceptName."&kindN
ame=DRUG_KIND"; 
//Call to get the concept name 
$XML=simpleXML_load_file($URL); 
//Parsing the document 
$conceptNui = $XML->groupConcepts->concept->conceptNui; 
After getting the concept id, this is used to pull the complete information using 
the Rx Norm API. The below code uses the concept id and pulls all the information. 
$URL1 = "http://rxnav.nlm.nih.gov/REST/Ndfrt/allInfo/".$conceptNui; 
// Call to get all the details 
$XML1 = simpleXML_load_file($URL1); 
foreach($XML1->fullConcept->groupRoles->role as $child) 
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{               echo $child->roleName . “ - ”;   
  echo $child->concept->conceptName; 
} 
 
Figure 12: RxNorm Query System 
 
4.9 Linking Model with PubMed API 
 In this section, we will discuss how the query system results were used to pull the 
publications from the PubMed and how the publications were pulled using the PubMed 
API. 
 PubMed provides a RESTful webservice to pull all the publications related to the 
term passed in the webservice call. PubMed also takes multiple terms input and results 
the publications that consists of all the terms or the MeSHterms. We took advantage of 
this feature and built a publication query system on top of the clinical trials data model. 
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When a user searches for a term using the query type, then the top results with the best 
strength value are pulled from the database and these terms are sent into the PubMed 
webservice. This would result all the publications that consists of the terms or MeSH 
terms. The querying on the system is done similar to the methodology that is mentioned 
above (Linking with RxNorm). The code to pull the results from the PubMed webservice 
is as follows: 
outputString =  “condition_name"+AND + “drug”; 
$PubMedAPI = new PubMedAPI(); 
$idList = $PubMedAPI->getIdString($outputString); 
  $XML = $PubMedAPI->getXMLFromIds($idList); 
// Gets all the elements from the results returned from the API 
 foreach($XML->DocSum as $childDoc) 
  {  
// Builds the table to output in the frontend  
   $idDetails = $PubMedAPI->getIdDetails($childDoc);    
   echo "<tr>";    
    echo "<td>".$count."</td>"; 
    echo "<td>".$idDetails->title."</td>"; 
    echo "<td>".$idDetails->author."</td>"; 
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    echo "<td>".$idDetails->publicationDate."</td>";  
  
   echo "</tr>";    
  } 
 
 
Figure 13: PubMed Query System 
 The entire code for the medical application is uploaded into the Github and the 
url for the code is: https://github.com/pramodgupta/Evidence-based-Medical-Query-
System. 
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4.10 Summary 
 In the Implementation section, we have discussed the implementation of each and 
every step of building the Evidence based Query model. Starting the Hadoop cluster 
setup, MetaMap setup, linking with MetaMap, the process of loading the data into 
MySQL, building the query system, linking the model with RxNorm and PubMed were 
discussed in this implementation section. 
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CHAPTER 5 
RESULTS & EVALUATION 
5.1 Overview 
 In this section, we will discuss about the results that are observed after building 
the query model. The various medical queries that can be addressed and evaluation of 
the system were also discussed. The time taken in each process and comparison between 
centralized vs distributed systems were also mentioned in this section. 
5.2 Results  
Medical Queries that can be addressed by this application: 
 All the medical queries that can be addressed by this application, which can be 
used by the Practitioners were explained in Table 2. 
Table 2: Medical Queries 
QUERY RESULT 
What is the drug of choice for condition 
(Prostate Cancer) 
Degarelix 
What is the cause of symptom (Cardiac 
Disorder)? 
Breast Cancer + docetaxel 
What are the sideeffect for condition 
(Lymphoma) 
Respiratory disorder 
What drug causes sideeffect (Psychiatric 
disorders) for condition (Schizophrenia) 
Placebo 
What sideEffect occurs for 
Condition(Colorectal Cancer) and drug 
(Oxaliplatin) 
Gastrointestinal disorders 
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QUERY RESULT 
What drug cannot be used with 
drug(Docetaxel) 
Gemcitabine 
Available modes of drug (Docetaxel) Oxaplatin 100 MG, Oxaplatin 500 MG 
All drugs for a Particular Condition Yes 
No. of conditions for which the drug can be 
used (Degarelix) 
3 
Percentage of People affected with a 
particular sideeffect(Vascular Disorder) for 
a particular drug(Degarelix) and 
condition(Prostate Cancer) combination 
6.25% 
Top 5 drugs for Condition (Prostate 
Cancer) 
Prednisone,Carlumab, Abiraterone, 
Carlumab, Tacrolimus 
 
Search on PubMed Publications based on Medical Condition/ Drug/ Side Effects: 
 User can search the application by Medical Condition/ Drug/ Side Effect by 
selecting the option in the drop down and entering the search term in the text box. This 
would fetch the results from the database with the best combination of drug and side 
effects and pull the PubMed publications using the PubMed API. Below is the screenshot 
of the system. 
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Figure 14: PubMed Results for Cancer Search Term 
 
Search based on Medical Condition/ Drug/ Side Effect with RxNorm drug details 
 User can search the application by Medical Condition/ Drug/ Side Effect by 
selecting the option in the drop down and entering the search term in the text box. This 
would fetch the results from the database with the best combination of drug and side 
effects along with the drug details from the RxNorm site using their API. Below is the 
screenshot of the system. 
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Figure 15: Application search results 
The Figure 16, show the side effects for the particular condition and drug 
combination that were observed in the research studies were mentioned. 
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Figure 16: Side Effects for Condition & Drug 
 
The drug details like the available versions in the market, the conditions in which 
drug cannot be used, the conditions that can be treated along with this drug, physiological 
effects and medical conditions this could induce will be show using the view drug details 
button. 
 
Figure 17: RxNorm Drug Details 
5.3 Evaluation 
Query comparison between PubMed and Current System 
We used the Clinical Trials data along with MetaMap scores and terms as the data source. 
We ran the same queries on the search application and PubMed and compared the output 
results. 
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Table 3: Comparison between PubMed and Application Results 
QUERY APPLICATION RESULTS PUBMED RESULTS 
Medical Condition  All the publications with the 
condition along with the 
drug having highest 
frequency and having less 
side effect percentage. 
 
All the publications with 
the medical term ordered 
by the PubMed criteria. 
Drug  All publications with the 
drug along with the 
condition and sideeffect  
having highest frequency 
and less percentage 
effected. 
All publications with the 
drug term. 
Side Effect All publications with the 
side effect along with the 
condition and drug having 
highest frequency and less  
percentage effected. 
All publications with the 
side effect term in the 
abstract. 
 
Medication Condition (Prostate Cancer) 
In the below mentioned table, the PubMed results consists of the publications 
only with the Prostate Cancer term mentioned , where as the results from my application 
consists of the all the publications with combination of Prostate Cancer(Medical 
Condition), Degarelix (Drug) and Nervous disorder(Side Effect). 
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Table 4: Comparison between PubMed and Application Results for Prostate Cancer 
APPLICATION RESULT TITLES PUBMED RESULT TITLES 
Degarelix versus Goserelin plus 
Bicalutamide Therapy for Lower Urinary 
Tract Symptom Relief, Prostate Volume 
Reduction and Quality of Life 
Improvement in Men with Prostate 
Cancer. 
PubMed ID: 24603064 
Correlation of Sprouty1 and Jagged1 with 
Aggressive Prostate Cancer Cells with 
Different Sensitivities to Androgen 
Deprivation. 
PubMed ID: 24604720 
A cost-utility analysis of degarelix in the 
treatment of advanced hormone-
dependent prostate cancer. 
PubMed ID: 24568188 
Protocol for the ProCare Trial: a phase II 
randomised controlled trial of shared care 
for follow-up of men with prostate cancer. 
PubMed ID: 24604487 
Prostate cancer: Tipping the balance in 
favour of degarelix for ADT. 
PubMed ID: 24473414 
  
The likelihood of death from prostate 
cancer in men with favorable or 
unfavorable intermediate-risk disease. 
PubMed ID: 24604289  
Disease Control Outcomes from Analysis 
of Pooled Individual Patient Data from 
Five Comparative Randomised Clinical 
Trials of Degarelix Versus Luteinising 
Hormone-releasing Hormone Agonists. 
PubMed ID: 24440304  
A High-Affinity Near-Infrared Fluorescent 
Probe to Target Bombesin Receptors. 
PubMed ID: 24604209 
  
Three-year follow-up of 12 patients with 
prostate cancer treated with monthly 
degarelix in a phase II clinical trial. 
PubMed ID: 24423954  
Alpha emitter radium-223 dichloride : New 
therapy in castration-resistant prostate 
cancer with symptomatic bone 
metastases. 
PubMed ID: 24604017 
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Drug  (Placebo) 
In the below mentioned table the results are the output for the search by drug 
criteria, the PubMed search results consists of all publications with placebo in the 
abstract, where as the results from the applications consists of all publications with a 
combination of Depression (Medical Condition), Placebo (Drug) and 
Psychiatric  disorders(Side Effect). 
Table 5: Comparison between PubMed and Application Results for Placebo  
APPLICATION RESULT TITLES PUBMED RESULT TITLES 
Design and Methodology for the Korean 
Observational and Escitalopram 
Treatment Studies of Depression in Acute 
Coronary Syndrome: K-DEPACS and 
EsDEPACS. 
PubMed ID: 24605129 
  
Design and Methodology for the Korean 
Observational and Escitalopram Treatment 
Studies of Depression in Acute Coronary 
Syndrome: K-DEPACS and EsDEPACS. 
PubMed ID: 24605129 
A comparison of responses to the positive 
and negative syndrome scale (PANSS) 
between patients with PTSD or 
schizophrenia. 
PubMed ID: 24602497 
  
Efficacy and Tolerability of Benzodiazepines 
for the Treatment of Behavioral and 
Psychological Symptoms of Dementia: A 
Systematic Review of Randomized 
Controlled Trials. 
PubMed ID: 24604893 
  
Omega-3 Fatty Acids in the Prevention of 
Interferon-Alpha-Induced Depression: 
Results from a Randomized, Controlled 
Trial. 
PubMed ID: 24602409  
Efficacy of combination therapy with 
erythropoietin and methylprednisolone in 
clinical recovery of severe relapse in 
multiple sclerosis. 
PubMed ID: 24604685 
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APPLICATION RESULT TITLES PUBMED RESULT TITLES 
Predictors of functional improvement in 
employed adults with major depressive 
disorder treated with desvenlafaxine. 
PubMed ID: 24583567 
  
Efficacy and Safety of Vildagliptin as Add-on 
to Metformin in Japanese Patients with 
Type 2 Diabetes Mellitus. 
PubMed ID: 24604395 
  
 
Side Effect (Vascular Disorder) 
In the below mentioned table the results are the output for the search by side 
effect criteria, the PubMed search results consists of all publications with vascular 
disorder in the abstract, whereas the results from the applications consists of all 
publications with a combination of Colorectal cancer (Medical Condition), Oxalipatin 
(Drug) and Vascular disorder (Side Effect). 
Table 6: Comparison between PubMed and Application Results for Vascular Disorder 
APPLICATION RESULT TITLES PUBMED RESULT TITLES 
Se-methylselenocysteine offers selective 
protection against toxicity and 
potentiates the antitumour activity of 
anticancer drugs in preclinical animal 
models. 
PubMed ID: 24619073 
Decreased tumour necrosis factor alpha 
(tnf-a) in serum of patients with achilles 
tendinopathy: further evidence against the 
role of inflammation in the chronic stage. 
PubMed ID: 24583567 
Improved time to treatment failure with 
an intermittent oxaliplatin strategy: 
results of the CONcePT trial. 
PubMed ID: 24608198 
Vascular mediators in chronic lung disease 
of infancy: Role of endothelial monocyte 
activating polypeptide II (EMAP II). 
PubMed ID: 24619875 
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Five Fractions of Radiation Therapy 
Followed by 4 Cycles of FOLFOX 
Chemotherapy as Preoperative Treatment 
for Rectal Cancer  
PubMed ID: 24606849 
Light chain deposition disease without 
glomerular proteinuria: a diagnostic 
challenge for the nephrologist.  
PubMed ID: 24619059  
 
Chemotherapy for elderly patients with 
colorectal cancer  
PubMed ID: 24739896 
  
 
Extracellular matrix assessment of infected 
chronic venous leg ulcers: role of 
metalloproteinases and inflammatory 
cytokines.  
PubMed ID: 24618232 
  
CLICNICAL TRIALS DATA ANALYTICS 
Top Medical Conditions 
 All the top conditions observed in the data set were mentioned in Table 7. In the 
dataset, Breast Cancer is the condition that has been observed in 1536 research studies 
which makes it around 12% among the entire research studies. 
Table 7: Top Ten Medical Conditions 
Condition Frequency 
Breast Cancer 1536 (12%) 
Prostate Cancer 922 (7%) 
Myeloma 809 (6.5%) 
Schizophrenia 796 (6.4%) 
Leukemia 781 (6.3%) 
Lung Cancer 741 (6%) 
Ovarian Cancer 729 (5.9%) 
Lymphoma 698 (5.6%) 
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Myelodysplastic Syndromes 609 (4.9%) 
Colorectal Cancer 598 (4.8%) 
 
Top Drugs 
 All the top drugs observed in the research studies were mentioned in the Table 8. 
Placebo is the drug that has been observed in 3435 studies that makes it around 28% 
among the entire dataset. 
Table 8: Top Ten Drugs 
Drug Frequency 
Placebo 3435 (28%) 
Cisplatin 1189 (9.6%) 
Paclitaxel 1158 (9.3%) 
Carboplatin 1118 (9.0%) 
Cyclophosphamide 901 (7.3%) 
Bevacizumab 886 (7.1%) 
Docetaxel 660 (5.3%) 
Gemcitabine 610 (4.9%) 
Lenalidomide 601 (4.8%) 
Pemetrexed 589 (4.7%)  
 
Top Side Effects 
All the top side effects observed in the research studies were mentioned in the 
Table 9. Gastrointestinal disorders is the Side Effect that has been observed in 4451 
studies that makes it around 36% among the entire dataset. 
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Table 9: Top Ten Side Effects 
Side Effect Frequency 
Gastrointestinal disorders 4451 (36%) 
Nervous system disorders 3856 (31%) 
Respiratory, thoracic and mediastina 
disorders 
3781 (30%) 
Blood and lymphatic system disorders 3664 (29.7%) 
Cardiac disorders 3472 (28%) 
Vascular disorders 3147 (25.5%) 
Metabolism and nutrition disorders 3101 (25.1%) 
Renal and urinary disorders 2750 (22.3%) 
Musculoskeletal and connective tissue 
disorders 
2571 (20.8%) 
Psychiatric disorders 2386 (19.3%) 
 
Top Condition and Drug Combination  
All the top condition and drug combinations observed in the research studies were 
mentioned in the Table 10. Prostate cancer and Degarelix is the combination that has 
been observed in 627 studies which makes it around 5% among the entire dataset. 
Table 10: Top Ten Condition and Drug Combinations 
Condition  Drug Frequency 
Prostate Cancer  Degarelix 627 (5%) 
Breast Cancer  Docetaxel 223 (1.8%) 
Colorectal Cancer  Oxaliplatin 202 (1.6%) 
Myeloma  Dexamethasone 192 (1.5%) 
Depressive Disorder  Placebo 162 (1.3%) 
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Breast Cancer Cyclophosphamide 161 (1.3%) 
Prostatic Neoplasms Prednisone 158 (1.28%) 
Alzheimers Disease Placebo 154 (1.24%) 
Lymphoma Cyclophosphamide 148 (1.2%) 
Leukemia Cyclophosphamide 139 (1.1%) 
 
Top Drug and Side Effect Combination 
All the top Side Effect and Drug combinations observed in the research studies 
were mentioned in the Table 11. Placebo and Depression disorder is the combination that 
has been observed in 443 studies which makes it around 3.5% among the entire dataset. 
Table 11: Top Ten Drug and Side Effect Combinations 
Drug Side Effect Frequency 
Placebo  Depression disorder 443 (3.5%) 
Placebo  Nervous 420 (3.4%) 
Placebo  Gastrointestinal 
disorders 
411 (3.3%) 
Bevacizumab   Vascular disorder 150 (1.2%) 
carboplatin  Blood and lymphatic 
system disorders 
136 (1.1%) 
Bevacizumab Nervous system 
disorders 
134 (1.08%) 
Placebo Vascular disorder 131 (1.06%) 
Cisplatin Gastrointestinal 
disorders 
121 (0.99%) 
paclitaxel Gastrointestinal 
disorders 
119 (0.97%) 
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cyclophosphamide Infections and 
infestations 
114 (0.92%) 
 
Top Condition and Side Effect Combination 
All the top Condition and Side Effect combinations, observed in the research 
studies were mentioned in the Table 12. Placebo and Depression disorder is the 
combination that has been observed in 443 studies which makes it around 3.5% among 
the entire dataset. 
Table 12: Top Ten Condition and Side Effect Combinations 
Condition Side Effect Frequency 
Breast Cancer   Blood and lymphatic 
system disorders 
221 (1.7%) 
Breast Cancer  Nervous System disorder 191 (1.54%) 
Schizophrenia  Psychiatric disorders 185 (1.5%) 
Leukemia Infections and 
infestations 
151 (1.2%) 
Prostate Cancer  Renal and urinary 
disorders 
115 (0.93%) 
Prostate Cancer Gastrointestinal 
disorders 
108 (0.87%) 
Lymphoma Respiratory, thoracic and 
mediastinal disorders 
105 (0.85%) 
Breast Cancer Hepatobiliary disorders 101 (0.81%) 
Myeloma Infections and 
infestations 
93 (0.75%) 
Prostate Cancer Neoplasms benign 91 (0.73%) 
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Top Condition, Drug and Side Effect Combinations 
All the top Condition, Drug and Side Effect combinations, observed in the research 
studies were mentioned in the Table 13. Prostate Cancer, Nervous system disorder and 
Degarelix is the combination that has been observed in 443 studies which makes it around 
3.5% among the entire dataset. 
Table 13: Top Ten Condition, Drug and Side Effect Combinations 
Condition Side Effect Drug Strength 
Prostate Cancer Nervous system disorders Degarelix 1 
Prostate Cancer Gastrointestinal disorders Degarelix 0.97 
Major Depressive 
Disorder 
Psychiatric disorders Placebo 0.873 
Schizophrenia Psychiatric disorders Placebo 0.65 
Breast Cancer Cardiac disorders Docetaxel 0.52 
Lymphoma Respiratory, thoracic and 
mediastinal disorders 
Cyclophosphamide 0.19 
Prostate Cancer Neoplasms benign, 
malignant and unspecified 
(incl cysts and polyps) 
Degarelix 0.188 
Breast Cancer Blood and lymphatic 
system disorders 
Docetaxel 0.109 
Prostate Cancer Surgical and medical 
procedures 
Degarelix 0.1 
 
Top Apriori Rules 
 All the top rules that are observed when the Apriori rule mining algorithm is used 
on the clinical trials data set are mentioned in Table 14.  
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Table 14: Top Ten Apriori Rules 
Condition Side Effect Drug Association 
Prostate Cancer Nervous system disorders Degarelix 0.94 
Prostate Cancer Gastrointestinal disorders  0.931 
Schizophrenia Psychiatric disorders Placebo 0.92 
Breast Cancer  Docetaxel 0.87 
Lymphoma Respiratory, thoracic and 
mediastinal disorders 
Cyclophosphamide 0.87 
Breast Cancer Blood and lymphatic 
system disorders 
Docetaxel 0.84 
Major Depressive 
Disorder 
 Placebo 0.71 
Prostate Cancer  Degarelix 0.72 
 
Top Common rules from Apriori and Combination Strength method 
 All the common combinations among the Apriori rule mining method and the 
Combination strength method are mentioned in Table 15. 
Table 15: Common Apriori and Combination Strength Rules 
Condition Side Effect Drug 
Prostate Cancer Nervous system disorders Degarelix 
Schizophrenia Psychiatric disorders Placebo 
Breast Cancer Cardiac disorders Docetaxel 
Lymphoma Respiratory, thoracic and 
mediastinal disorders 
Cyclophosphamide 
Breast Cancer Blood and lymphatic system 
disorders 
Docetaxel 
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Combinations vs Association Criteria’s 
 Figure 18 explains how the no. of combinations changes depending upon the value 
of combination strength or confidence or support. The graph shows the no. of 
combinations available at the particular combination strength or confidence or support. 
When we increase the value of the combination strength or confidence or support the 
no. of combinations at that particular value decreases.  
 
Figure 18: Combinations vs Association Rules 
Data Statistics 
 In Table 16, all the data statistics observed in the clinical trials data set collected 
were mentioned. Total no. of unique conditions, drugs, side effects observed were also 
mentioned the in table. Total combinations observed, subjects considered for the 
research studies and the apriori rules generated were also mentioned in the table. 
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Table 16: Data Statistics 
Type Count 
Conditions 1761 
Drugs 2836 
Side Effects 27 
Total Subjects 432,841 
Total research studies 12,327 
Total Combinations (Condition / Drug/ 
Side Effect) 
59,228 
Total Apriori rules 8,291 
Total MetaMap Mappings 9,719 
Total Common rules 6,724 
 
Time Comparison 
  The below chart shows the time comparison between the Distributed 
system vs Centralized system for the Data Analysis and the MetaMap Linking 
Data Analysis: This is the process of analyzing the clinical trials data and write the 
required data to an external file. 
MetaMap Linking: This is the process to pull the Meta score and the related medical 
terminology of the medical conditions and drugs which can be further used at the time of 
querying the data model. 
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Figure 19: Time Comparison between Centralized vs Distributed 
 
Time taken in Process 
 The time taken in each process in building the data model is mentioned in the 
below table. 
Table 17: Time in Process 
STEP TIME TAKEN 
Loading Clinical trials data into Hadoop 48.7 min 
Data Analysis 37.83 min 
MetaMap Linking 4.4 min 
Association Rule Mining 1.2 min 
Export results to MySQL Database 2 min 
Query 1.2 sec 
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Figure 20: Time taken in Process 
 
5.4 Summary 
 We have found the various unique drugs, conditions and side effects used in the 
research studies. We found the best combinations using the rule mining algorithms and 
combination strength values in the entire research studies. We were able to compare the 
performance of centralized vs the distributed systems. 
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CHAPTER 6 
CONCLUSION AND FUTURE WORK 
6.1 Conclusion 
In this section, the contribution of this thesis is summarized. We presented a novel 
approach to query the medical data on large scale.  We successfully implemented the 
data analysis of clinical trials data on distributed environment (Hadoop Framework) and 
link the results with MetaMap to find the meta score and related medical terminology. 
We calculated the Effective strength of the combination of Condition, Drug and Side effect 
for querying the system. We found the association rules on the data using the Apriori 
algorithm. 
We have successfully implemented an Evidence based query model using the 
strength of the combination to present the best combinations possible for the search 
term. We have successfully integrated this data model with PubMed API and RxNorm to 
present the publications based on the combinations resulted from querying the system. 
6.2 Future Work 
 In this section, we will discuss about the possible enhancements and extensions 
of this thesis project. After the data analysis in the distributed system, the output is linked 
with the MetaMap server in the centralized data nodes. This can be enhanced by 
implementing the MetaMap linking in distributed environment by hosting the MetaMap 
server online and linking to the URL directly from the MapReduce.  
 The results from the MapReduce after linking with the MetaMap is moved to the 
centralized MySQL database. Instead of moving the data to a centralized system, it can 
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be moved to the HBase tables in distributed system and build the query system on top of 
HBase in the distributed system.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
REFERENCES 
[1] Ablimit Aji, Fusheng Wang, Joel Saltz, “Towards building a high performance 
spatial query system for large scale medical imaging data”, Department of 
Mathematics & Computer Science, Emory University, GA, 2012. Available: 
http://confluence.cci.emory.edu:8090/download/attachments/6193390/SIGSpat
ial2012TechReport.pdf?version=1&modificationDate=1350335703000 
[2] Apache (1999), Apache Software Foundation, Available: http://www.apache.org/. 
[3] Chris Stotle, Diane Tang, and Pat Hanrahan, “A system for query, analysis of 
multidimensional relational databases”, IEEE Transactions on visualization, 2002. 
Available: http://graphics.stanford.edu/papers/polaris_extended/polaris.pdf 
[4] Clinical Trials Data Repository, National Institute of Health, Available: 
http://www.clinicaltrials.gov/ 
[5] Cochrane Collaboration (1993), Independent NPO, Available: 
http://www.cochrane.org/ 
[6] Creately (2008), Cinergix Inc., Available:  https://creately.com 
[7] Dennis Wollershiem, “Ontology based query expansion framework for use in 
medical information systems”, La Trobe University, Melbourne, Australia, 2005. 
Available:http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.59.1543&r
ep=rep1 &type=pdf 
[8] Durk Alan (2005), MetaMap, Available: http://MetaMap.nlm.nih.gov/ 
[9] Eric Sayers (2008), Entrez Programming Utilities, Available:  
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/ 
63 
 
[10] Gerald Peter Quinin, “Experimental design and data analysis for biologists”, 
Cambridge University, 2002. Available: http://www.lacbiosafety.org/wp-
content/uploads/2011/09/experimental-design-and-data-analysis-for-
biologists1.pdf 
[11] Giorgio Orsi, Letizia Tanca, “Keyword-based, Context-aware selection of natural 
language query patterns”, Universitá del Sannio, Italy, 2011. Available: 
http://www.edbt.org/Proceedings/2011-Uppsala/papers/edbt/a18-orsi.pdf 
[12] Google Code (2005), Google Inc.  Available : http://code.google.com 
[13] Hadoop (2004) , Apache Software Foundation,  Available:  
http://hadoop.apache.org/ 
[14] HIVE, Apache Software Foundation, Available: http://hive.apache.org/ 
[15] Jeremy Ginsberg, Matthew H. Mohebbi, “Detecting influenza epidemics using 
search engine query data”, Nature Vol 457, Google Inc, 2009. Available: 
http://static.googleusercontent.com/media/research.google.com/en/us/archive
/papers/detecting-influenza-epidemics.pdf 
[16] Lipyeow Lim, Min Wang, “Supporting keyword based search on medical 
repositories”, Ph.D, Watson Research Center, Hawthorne, NY, 2008, Available: 
http://www2.hawaii.edu/~lipyeow/pub/amia08-ontkeyword.pdf 
[17] Medline Plus(1998) , NLM, Available: http://www.nlm.nih.gov/medlineplus/ 
[18] MySQL(1995), Oracle Corporation, Available: http://www.MySQL.com/ 
[19] National Institute of Health, US Department of Health & Human Sciences, 
Available:  http://www.nih.gov/ 
64 
 
[20] NLM API Service (2001), National Library of Medicine, Available: 
http://www.nlm.nih.gov/API/ 
[21] Ping Chen, Rakesh Verma, “A Query-based medical information summarization 
system using ontology knowledge”, University of Houston Downtown, TX,2006, 
Available:http://ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=1647543&url=
http%3A%2F%2Fieeexplore.ieee.org%2Fiel5%2F10953%2F34552%2F01647543 
[22] Pubmed , National Institute of Health, Available: 
http://www.ncbi.nlm.nih.gov/pubmed 
[23] Radu Calinescu, Steve Harris, “Cross-Trial query system for cancer clinical trials”, 
Computing Laboratory, University of Oxford, , Oxford, UK, 2007, Available: 
http://www.cs.ox.ac.uk/jeremy.gibbons/publications/crosstrial.pdf 
[24] RxNorm, Unified Medical Language System (UMLS), Available: 
https://www.nlm.nih.gov/research/umls/rxnorm/ 
[25] RxNorm API (2010), NLM , Available: http://rxnav.nlm.nih.gov/REST/ 
[26] Stack Overflow (2008), Stack Exchange Inc, Available: http://stackoverflow.com/ 
[27] Tom Preston (2008), Git Hub , Available: http://github.com 
[28] Unified Medical Language System (1986), NLM, Available: 
http://www.nlm.nih.gov/research/umls/ 
[29] VMWare Workstation (1999) , VMWare, Available: 
http://www.vmware.com/products/workstation 
[30] Zafar Hashmi , Tatjana Zrimec, " Automatic query generation from computerized 
clinical guidelines”, International Journal of Information Studies, Vol 1, No 4 
65 
 
(2009),Available:http://www.istudies.net/ojs/index.php/journal/article/viewFile/
61/50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
VITA 
Venkata Pramod Gupta Bavirisetty was born on March 24, 1990, in 
Visakhapatnam, India. He completed his schooling in Nellore and graduated high school 
in 2007. He then completed his Bachelor’s degree in Biotechnology from National 
Institute of Technology, Warangal, India in 2011. Upon the completion of his Bachelor’s 
he was placed in Automatic Data Processing as a Software Engineer. 
In August 2012, Mr. Venkata Pramod Gupta Bavirisetty came to United States to 
study Computer Science at the University of Missouri- Kansas City (UMKC), specializing in 
Software Engineering. Upon completion of his requirements for the Master’s Program, 
Mr. Venkata Pramod Gupta Bavirisetty plans to work for Epic, Madison. 
